Flushed with Success: Flushing Financial Keeps its Investment Grade Rating with Kroll Bond Rating Agency Inc.

Flushing Financial Maintains Its Investment Grade Rating by Kroll Bond Rating Agency, Inc. UNIONDALE, N.Y., Nov. 09, 2022 (GLOBE NEWSWIRE) Flushing Financial Corporation (the “Company”) (Nasdaq: FFIC), the parent holding company for Flushing Bank (the “Bank”), announced today that Kroll Bond Rating Agency (“KBRA”), a full-service rating agency, reaffirmed an investment grade rating for the…

Read More

“Attention Shareholders: Important Notification from Levi and Korsinsky LLP Regarding Your Investments”

Levi & Korsinsky, LLP Launches Investigation into the Acquisition of Senti Biosciences Inc New York, NY / AccessWire / January 30, 2025 The legal firm Levi & Korsinsky, LLP has recently announced that it has initiated an investigation into the acquisition of Senti Biosciences Inc (NASDAQ:SNTI), previously known as Dynamics Special Purpose Co. Investors who…

Read More

Viral YouTuber Endorses BlockDAG: Presale Surpasses Ethereum and Polkadot, Raising $29.2M

In the turbulent cryptocurrency market, BlockDAG stands out with a $29.2 million presale Revolutionizing the Industry BlockDAG has made waves in the cryptocurrency industry with its successful $29.2 million presale. This achievement comes at a time when major players like Ethereum are facing challenges, and Polkadot is working on improving its smart contract capabilities. The…

Read More

Unleashing the Scoop: Iterum Therapeutics PLC’s Q2 2024 Earnings Call – A Playful and Informative Rewrite!

Iterum Therapeutics Q2 2024 Results Conference Call – A Recap Welcome, Fellow Financial Enthusiasts! It’s that time again – when we gather around our virtual meeting rooms to dissect the latest financial results and business updates from Iterum Therapeutics. So grab your favorite cup of coffee, get cozy, and let’s dive right into the nitty-gritty…

Read More

Breaking News: Apollo Funds and Rettig Join Forces to Acquire 94.53% Stake in Purmo Group Plc

Apollo Acquires Majority Stake in Purmo Group Plc Setting the Stage for a Sustainable Future In a move that highlights the growing significance of sustainable practices in the business world, Apollo (NYSE: APO) has announced the completion of its acquisition of a 94.53% equity stake in Purmo Group Plc. This strategic investment, made through Apollo-managed…

Read More

CSL’s Garadacimab Receives Positive CHMP Opinion for Hereditary Angioedema (HAE)

CSL’s Breakthrough in HAE Treatment Empowering the HAE Community CSL’s latest announcement regarding the positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) on garadacimab marks a significant milestone in the treatment of hereditary angioedema (HAE). If approved, garadacimab will be the first and only once-monthly treatment inhibiting factor…

Read More